Soleno Therapeutics makes first commercialised drug for extreme hunger caused by Prader-Willi syndrome
Flight prices surging amid Iran war
...
Read moreDetailsHome » Neurocrine nears $2.5bn-plus deal for biotech behind obesity disorder treatment
Soleno Therapeutics makes first commercialised drug for extreme hunger caused by Prader-Willi syndrome
...
Read moreDetails